치료반응 예측 바이오마커 기반의 혁신항암제 전문개발기업
Location: South Korea, Seoul
Employees: 51-200
Investors 3
Date | Name | Website |
- | Muirwoods ... | muirwoodsv... |
21.12.2021 | Krypton | krypton36.... |
- | The Yozma ... | korea.yozm... |
Mentions in press and media 1
Date | Title | Description | Source |
03.03.2021 | WellmarkerBio receives approval for Phase I clinical trial f... | prnewswire... |